The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Sex Difference in Risk of Torsade de Pointes With d,l- Sotalol
Abstract
Background The present study was undertaken to test the hypothesis that women are more prone than men to develop torsade de pointes (TdP) in a defined cohort of patients exposed to the QT-prolonging antiarrhythmic drug d,l -sotalol. Methods and Results In a database derived from 22 clinical trials involving 3135 adult patients who received oral d,l -sotalol (median follow-up, 164 days), TdP developed in 44 (1.9%) of 2336 men and in 33 (4.1%) of 799 women ( P <.001). Logistic regression analysis identified female sex ( P <.0001), presenting arrhythmia of sustained ventricular tachycardia or fibrillation ( P <.0001), history of congestive heart failure ( P <.001), and d,l -sotalol dose >320 mg/d ( P <.001) as factors most predictive of TdP; in addition to these, a serum creatinine >1.4 mg/dL in women and >1.6 mg/dL in men was weakly predictive ( P <.05). After adjustment for these risk factors, women had threefold greater odds of developing TdP than men. The sex difference in TdP risk was age independent and could not be explained by differential dose-related bradycardic responses in women versus men. Conclusions Women are at increased risk of developing TdP during administration of d,l -sotalol. This finding needs to be taken into account, together with other TdP risk factors, when patients are treated with this antiarrhythmic agent. Given the consistency between the present and other recent observations, greater caution in women regarding use of QT-prolonging drugs, in general, is advisable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Cardiac Electrophysiology: From Cell to Bedside
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1069_5 · Cited by 2,385
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
The long QT syndrome. Prospective longitudinal study of 328 families.
Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J., Hall, W. J., Weitkamp, L., Vincent, G. M., & Garson, A. (1991) · Circulation · doi:10.1161/01.cir.84.3.1136 · Cited by 968
The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
Jackman, W. M., Friday, K. J., Anderson, J. L., Aliot, E. M., Clark, M., & Lazzara, R. (1988) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(88)90014-x · Cited by 783
Sex differences in the evolution of the electrocardiographic QT interval with age.
Rautaharju, P. M., Sh, Z., Wong, S., Hp, C., Berenson, G. S., Prineas, R., & Davignon, A. (1992) · PubMed · Cited by 635
Neal Kay, G., Vance J., P., Joaquin G., A., Richard W., H., & Albert L., W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463
A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias
Mason, J. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308123290702 · Cited by 462
Drici, M. D., Burklow, T. R., Haridasse, V., Glazer, R. I., & Woosley, R. L. (1996) · Circulation · doi:10.1161/01.cir.94.6.1471 · Cited by 372
Roden, D. M., & Hoffman, B. F. (1985) · Circulation Research · doi:10.1161/01.res.56.6.857 · Cited by 340
"Les Torsades de Pointes": An Unusual Ventricular Arrhythmia
SMITH, W. M., & GALLAGHER, J. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-578 · Cited by 251
Comprehensive Electrocardiology : Theory and Practice in Health and Disease
Macfarlane, P. W., & Lawrie, T. D. V. (1989) · Medical Entomology and Zoology · Cited by 243
Torsade de pointes due to quinidine: Observations in 31 patients
Bauman, J. L., Bauernfeind, R. A., Hoff, J. V., Strasberg, B., Swiryn, S., & Rosen, K. M. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90081-4 · Cited by 208
Should clearance be normalised to body surface or to lean body mass?
Hallynck, T., Soep, H. H., Thomis, J. A., Boelaert, J. R., Daneels, R. F., & Dettli, L. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01163.x · Cited by 155
Risk of cardiac events in family members of patients with long QT syndrome
Zareba, W., Moss, A. J., le Cessie, S., Locati, E. H., Robinson, J. L., Hall, W. J., & Andrews, M. L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)60383-2 · Cited by 142
Clinical features of the idiopathic long QT syndrome.
Moss, A. J., & Robinson, J. (1992) · PubMed · Cited by 126
Community-based interventions for sudden cardiac death. Impact, limitations, and changes.
Cobb, L. A., Weaver, W. D., Fahrenbruch, C. E., Hallstrom, A. P., & Copass, M. K. (1992) · PubMed · Cited by 119
Probucol-associated tachyarrhythmic events and QT prolongation: Importance of gender
Reinoehl, J., Frankovich, D., Machado, C., Kawasaki, R., Baga, J. J., Pires, L. A., Steinman, R. T., Fromm, B. S., & Lehmann, M. H. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90095-2 · Cited by 109
Self-citationThe duration of the Q-U interval and its components in electrocardiograms of normal persons
Lepeschkin, E., & Surawicz, B. (1953) · American Heart Journal · doi:10.1016/0002-8703(53)90237-3 · Cited by 98
Increased Propensity of Women to Develop Torsades de Pointes During Complete Heart Block
Kawasaki, R., Machado, C., Reinoehl, J., Fromm, B. S., Baga, J. J., Steinman, R. T., & Lehmann, M. H. (1995) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1995.tb00380.x · Cited by 94
Self-citationThe Normal Electrocardiogram and Vectorcardiogram
(2012) · Springer eBooks · doi:10.1007/springerreference_188088 · Cited by 74
Berger, D. S., & Li, J. K. ‐. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90027-x · Cited by 56
Sotalol-induced torsade de pointes
Kück, K., Kunze, K.-P., Roewer, N., & Bleifeld, W. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90158-3 · Cited by 50
Sex Differences in Phenotypic Manifestation and Gene Transmission in the Romano‐Ward Syndrome
Hashiba, K. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb31008.x · Cited by 42
Sotalol for paroxysmal supraventricular tachycardias
Camm, A. J., & Paul, V. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90206-g · Cited by 35
Jereczek, M., Andresen, D., Schröder, J., Völler, H., Brüggemann, T., Deutschmann, C., & Schröder, R. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90210-4 · Cited by 28
Sotalol-induced torsade de pointes: management with magnesium infusion
Arstall, M. A., Hii, J. T. Y., Lehman, R. G., & Horowitz, J. D. (1992) · Postgraduate Medical Journal · doi:10.1136/pgmj.68.798.289 · Cited by 28
Cited by
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Nattel, S., Maguy, A., Le Bouter, S., & Yeh, Y.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00014.2006 · Cited by 858
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
(2016) · European Heart Journal · doi:10.1093/eurheartj/ehv598 · Cited by 739
Writing Committee Members, Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., et al. (2006) · Europace · doi:10.1093/europace/eul108 · Cited by 738
Haverkamp*, W. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00119-x · Cited by 486
Metadata
- Authors
- Lehmann, M. H., Hardy, S., Archibald, D., Quart, B., & MacNeil, D. J.
- Venue
- Circulation
- Published
- 1996-11-15
- Volume
- 94
- Issue
- 10
- Pages
- 2535-2541
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2135884250
- Cited by
- 458
- References
- 27
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.